Literature DB >> 20538666

AMIS Plus: Swiss registry of acute coronary syndrome.

Dragana Radovanovic1, Paul Erne.   

Abstract

UNLABELLED: AIMS OF AMIS PLUS: To learn from each other, to understand the transfer, use and practicability of knowledge gained from randomised trials and to generate input for subsequent prospective and randomised studies. Furthermore, to determine how adherence to guideline-based treatments in the 'real world' works. FUNDING: AMIS Plus is an industry-sponsored project but the supporting institutions do not play any part in the design of the registry, data collection, analysis or interpretation. QUALITY-OF-CARE
INTERVENTIONS: AMIS Plus data enable doctors to identify deficits in medical care, implement the necessary changes in diagnostics and therapeutic procedures and document their impact on clinical outcome in patients with acute coronary syndrome (ACS).
SETTING: From 106 hospitals treating ACS in Switzerland, 76 hospitals temporarily or continuously enrolled patients in AMIS Plus. Years: 1997- . POPULATION: Patients are included on the basis of their final diagnosis. Current number of cases: 33 040. START POINTS: ST elevation myocardial infarction, non-ST elevation myocardial infarction and since 2000, unstable angina. BASELINE DATA: 230 variables are collected including demographics, medical history, cardiovascular risk factors, acute symptoms, time of symptom onset, first medical contact, time of admission and start of thrombolysis or balloon, out of hospital management, clinical presentation, early in-hospital management, reperfusion treatment, hospital course, diagnostic tests used or planned, hospital length of stay, discharge medication, destination and at 1 year, outcome, rehospitalisation, intervention, working time and quality of daily life. DATA CAPTURE: Data are provided through an internet- or paper-based questionnaire completed by the treating doctor or a trained study nurse. DATA QUALITY: The data are centralised at the AMIS Plus Data Center, checked for plausibility and consistency and crosschecked when queries arise. Incomplete questionnaires are returned to the enrolment centres for completion. One-third of the variables are obligatory. END POINT AND LINKAGES TO OTHER DATA: In-hospital outcome, 3-months and 1-year follow-up outcome. No linkages exist at present. ACCESS TO DATA: Available for research with the approval of the AMIS Plus Steering Committee. Participating hospitals use the data for benchmarking and their own quality control.

Entities:  

Mesh:

Year:  2010        PMID: 20538666     DOI: 10.1136/hrt.2009.192302

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  16 in total

1.  Gender-related mortality trends among diabetic patients with ST-segment elevation myocardial infarction: insights from a nationwide registry 1997-2010.

Authors:  Marco Roffi; Dragana Radovanovic; Paul Erne; Philip Urban; Stephan Windecker; Franz R Eberli
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-06-03

2.  Heart failure in patients admitted for acute coronary syndromes: A report from a large national registry.

Authors:  Raban V Jeger; Otmar Pfister; Dragana Radovanovic; Franz R Eberli; Hans Rickli; Philip Urban; Giovanni Pedrazzini; Jean-Christophe Stauffer; Jörg Nossen; Paul Erne
Journal:  Clin Cardiol       Date:  2017-06-09       Impact factor: 2.882

3.  Comparative trends in hospitalizations for osteoporotic fractures and other frequent diseases between 2000 and 2008.

Authors:  K Lippuner; S Grifone; M Schwenkglenks; P Schwab; A W Popp; C Senn; R Perrelet
Journal:  Osteoporos Int       Date:  2011-05-28       Impact factor: 4.507

4.  Temporal trends in treatment of ST-elevation myocardial infarction among men and women in Switzerland between 1997 and 2011.

Authors:  Dragana Radovanovic; Bramajee K Nallamothu; Burkhardt Seifert; Osmund Bertel; Franz Eberli; Philip Urban; Giovanni Pedrazzini; Hans Rickli; Jean-Christophe Stauffer; Stephan Windecker; Paul Erne
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-09

5.  Outcome of patients admitted with acute coronary syndrome on palliative treatment: insights from the nationwide AMIS Plus Registry 1997-2014.

Authors:  Paul Erne; Dragana Radovanovic; Burkhardt Seifert; Osmund Bertel; Philip Urban
Journal:  BMJ Open       Date:  2015-03-02       Impact factor: 2.692

6.  Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study.

Authors:  David Carballo; Cécile Delhumeau; Sebastian Carballo; Caroline Bähler; Dragona Radovanovic; Bernard Hirschel; Olivier Clerc; Enos Bernasconi; Dominique Fasel; Patrick Schmid; Alexia Cusini; Jan Fehr; Paul Erne; Pierre-Fréderic Keller; Bruno Ledergerber; Alexandra Calmy
Journal:  AIDS Res Ther       Date:  2015-02-22       Impact factor: 2.250

7.  The year of transparency: measuring quality of cardiac care.

Authors:  D C Eindhoven; E Wierda; M C de Bruijne; G Amoroso; B A J M de Mol; V A W M Umans; M J Schalij; C J W Borleffs
Journal:  Neth Heart J       Date:  2015-09       Impact factor: 2.380

8.  Trends in hospital discharges, management and in-hospital mortality from acute myocardial infarction in Switzerland between 1998 and 2008.

Authors:  Charlène Insam; Fred Paccaud; Pedro Marques-Vidal
Journal:  BMC Public Health       Date:  2013-03-25       Impact factor: 3.295

9.  Myocardial infarct size and mortality depend on the time of day-a large multicenter study.

Authors:  Stephane Fournier; Patrick Taffé; Dragana Radovanovic; Erik Von Elm; Beata Morawiec; Jean-Christophe Stauffer; Paul Erne; Ahmed Beggah; Pierre Monney; Patrizio Pascale; Juan-Fernando Iglesias; Eric Eeckhout; Olivier Muller
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

10.  Dual antiplatelet therapy is under-prescribed in patients with surgically treated acute myocardial infarction.

Authors:  Marco Roberto; Dragana Radovanovic; Carmelo Buttà; Gregorio Tersalvi; Joël Krüll; Paul Erne; Hans Rickli; Giovanni Battista Pedrazzini; Marco Moccetti
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.